A recent study found that the prevalence of thromboembolic events is increased in individuals with Dermatomyositis with ...

Dr. Stefan Plontke of Martin-Luther-University Halle-Wittenberg. AC102 is considered a promising alternative to corticoid therapy for sudden hearing loss, as it was able to restore hearing almost ...

Berlin-based start-up AudioCure Pharma has enrolled more than 50% of the planned patients in its ongoing Phase 2 clinical trial. The aim of the study is to test the efficacy of the new compound AC102 ...

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: The primary objective is to assess the benefits and harms of glucocorticoid facet joint injections in adults ...

A RECENT trial, known as the STAR study, compared two glucocorticoid tapering strategies in patients with rheumatoid arthritis (RA) in low disease activity (LDA) and found no significant difference in ...